ESTRO 2024 - Abstract Book

S4854

Physics - Quality assurance and auditing

ESTRO 2024

ΔDmean_Cochlea_L /Dmean_Cochlea_L (%)

12.80%

4.26%

Conclusion:

SPArc shows overall less sensitivity to the spot position perturbations compared to the conventional IMPT. This study also provides quantitative data and references for future SPArc QA investigations.

Keywords: Proton Arc therapy, quality assurance

References:

1. Ding, X. et al. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy. Int. J. Radiat. Oncol. Biol. Phys. 96, 1107–1116 (2016).